Curcumol induced apoptosis of human acute myeloid leukemia KG-1a cells

被引:0
|
作者
Li, Feng [1 ]
An, Qi [1 ]
Zhou, Yubing [1 ]
Li, Duolu [1 ]
Han, Chao [1 ]
Zhang, Xiaojian [1 ]
Kan, Quancheng [1 ]
机构
[1] Zhengzhou Univ, Dept Clin Pharmacol, Affiliated Hosp 1, Zhengzhou 450052, Peoples R China
来源
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE | 2016年 / 9卷 / 06期
关键词
Curcumol; apoptosis; caspases; mitochondrial membrane potential; KG-1a cell; human acute myeloid leukemia; MITOCHONDRIAL; MECHANISMS; CANCER; BAX;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objective: To investigate the effect of curcumol on the apoptosis of human acute myeloid leukemia KG-1a cells and to explore possible mechanism of action. Methods: CCK-8 method was used to detect the cell viability of KG-1a cells treated by 10, 20, 40, 60, 80 uM curcumol, and that of KG-1a cells treated by 40 uM curcumol after different periods of time. Confocal microscopy was used to observe morphologic changes after cells were incubated with 40 uM curcumol for 24 h and 48 h, respectively. Further, morphologic changes of the nucleus were observed after cells were stained by Hochest 33258. Annexin V-FITC/PI staining was also conducted. Then, after Rhodamine 123 staining of mitochondrial membrane potential specific probe, the decreasing ratio of mitochondrial membrane potential was detected with a flow cytometer. Finally, after cells were pretreated by a broad-spectrum caspase inhibitor z-VAD-fmk, the effect of curcumol on cell viability was tested and the expression of caspase 8, 9 and 3 was also detected by Western blot. Results: The inhibitive effect of curcumol on the viability of KG-1a cells showed significant concentration and time-dependence. The viability of cells treated by 10, 20, 40, 60 and 80 uM curcumol were (91.6 +/- 3.1)%, (74.1 +/- 3.4)%, (57.1 +/- 1.9)%, (37.9 +/- 2.3)% and (32.6 +/- 2.5)%, respectively. For cells treated by 40 uM curcumol for 6, 12, 24 and 48 h, their viability was (75.3 +/- 2.102)%, (50.6 +/- 1.9)%, (41.6 +/- 2.6)%, (20.1 +/- 2.1)%, respectively. Compared with blank control, cells treated by 40 uM curcumol for 24 h partially changed to round in shape and some dead ones floated, which was more obvious for cells treated for 48 h. In addition, nuclear staining showed shrinkage of nucleus and the presence of apoptotic body after treatment for 24 h, which was also more significant after treatment for 48 h. Apoptosis was confirmed by flow cytometry. Moreover, it was found that the mitochondrial membrane potential of cells treated by 40 uM curcumol for 24 and 48 h decreased remarkably, which was (43.1 +/- 1.9)% and (78.9 +/- 2.1)%, respectively (P<0.01). At last, before and after pretreatment with broad-spectrum caspases inhibitor z-VAD-fmk, the viability of cells treated for 24 h and 48 h presented no obvious change. Western blot found that caspases 8, 9 and 3 were not involved in the apoptosis induced by curcumol. Conclusion: Curcumol can decrease the viability of KG-1a cells and induce apoptosis via a possible mechanism of caspases-independent cell apoptosis caused by mitochondrial membrane potential dropping.
引用
收藏
页码:9999 / 10005
页数:7
相关论文
共 50 条
  • [1] Overexpression of MYCT1 Inhibits Proliferation and Induces Apoptosis in Human Acute Myeloid Leukemia HL-60 and KG-1a Cells in vitro and in vivo
    Fu, Shuang
    Fu, Yu
    Chen, Fang
    Hu, Yanping
    Quan, Bi
    Zhang, Jihong
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [2] Quercetin sensitizes human myeloid leukemia KG-1 cells against TRAIL-induced apoptosis
    Naimi, Adel
    Entezari, Atefeh
    Hagh, Majid Farshdousti
    Hassanzadeh, Ali
    Saraei, Raedeh
    Solali, Saeed
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (08) : 13233 - 13241
  • [3] Detection of apoptosis in KG-1a leukemic cells treated with investigational drugs
    Efferth, T
    Rucker, G
    Falkenberg, M
    Manns, D
    Olbrich, A
    Fabry, U
    Osieka, R
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1996, 46 (02): : 196 - 200
  • [4] Diosmetin Induces Apoptosis of Acute Myeloid Leukemia Cells
    Roma, Alessia
    Rota, Sarah G.
    Spagnuolo, Paul A.
    MOLECULAR PHARMACEUTICS, 2018, 15 (03) : 1353 - 1360
  • [5] CRNDE enhances the expression of MCM5 and proliferation in acute myeloid leukemia KG-1a cells by sponging miR-136-5p
    Liu, Chen
    Zhong, Liang
    Shen, Chenlan
    Chu, Xuan
    Luo, Xu
    Yu, Lihua
    Ye, Jiao
    Xiong, Ling
    Dan, Wenran
    Li, Jian
    Liu, Beizhong
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [6] Salinomycin overcomes ABC transporter-mediated multidrug and apoptosis resistance in human leukemia stem cell-like KG-1a cells
    Fuchs, Dominik
    Daniel, Volker
    Sadeghi, Mahmoud
    Opelz, Gerhard
    Naujokat, Cord
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 394 (04) : 1098 - 1104
  • [7] Targeting prohibitins induces apoptosis in acute myeloid leukemia cells
    Pomares, Helena
    Palmeri, Claudia M.
    Iglesias-Serret, Daniel
    Moncunill-Massaguer, Cristina
    Saura-Esteller, Jose
    Nunez-Vazquez, Sonia
    Gamundi, Enric
    Arnan, Montserrat
    Preciado, Sara
    Albericio, Fernando
    Lavilla, Rodolfo
    Pons, Gabriel
    Gonzalez-Barca, Eva M.
    Cosialls, Ana M.
    Gil, Joan
    ONCOTARGET, 2016, 7 (40) : 64987 - 65000
  • [8] Mechanistic aspects of lauryl gallate-induced differentiation and apoptosis in human acute myeloid leukemia cells
    Teng, Chieh-Lin Jerry
    Han, Shao-Min
    Wu, Wei-Cheng
    Hsueh, Chi-Mei
    Tsai, Jia-Rong
    Hwang, Wen-Li
    Hsu, Shih-Lan
    FOOD AND CHEMICAL TOXICOLOGY, 2014, 71 : 197 - 206
  • [9] Notopterol-induced apoptosis and differentiation in human acute myeloid leukemia HL-60 cells
    Huang, Qinwan
    Wang, Lin
    Ran, Qian
    Wang, Jin
    Wang, Chengqiang
    He, Hui
    Li, Li
    Qi, Hongyi
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 13 : 1927 - 1940
  • [10] Blocking protein geranylgeranylation is essential for lovastatin-induced apoptosis of human acute myeloid leukemia cells
    Z Xia
    MM Tan
    W Wei-Lynn Wong
    J Dimitroulakos
    MD Minden
    LZ Penn
    Leukemia, 2001, 15 : 1398 - 1407